We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.19 | -0.38% | 49.27 | 49.23 | 49.26 | 152 | 10:38:43 |
By Sonia Amaral Rohter
Sanofi SA (SAN.FR) said on Wednesday that fourth-quarter net profit decreased significantly due in part to a drop in sales and a tax-related charge.
The French drugmaker reported net profit of 129 million euros ($159.7 million) for the quarter, compared with EUR790 million in the same period a year earlier.
Business net income--the company's measure for adjusted income excluding the impact of acquisitions and divestments--was EUR1.33 billion, down from EUR1.61 billion. Sales for the quarter fell 2% to EUR8.69 billion.
A Vara Research consensus forecast had seen fourth-quarter business net income at about EUR1.43 billion and sales of about EUR8.7 billion
Sanofi recorded a charge of EUR631 million in the quarter that it said primarily reflected the consequences of the recent U.S. tax reform.
Global sales of Lantus--Sanofi's flagship diabetes product--dropped 21% at a constant exchange rate, while sales in the U.S. decreased 31.4%.
The company said that, including the anticipated contribution from recently announced acquisitions, it expects 2018 business earnings per share to increase between 2% and 5% at constant exchange rates. Sanofi estimates the currency impact on its 2018 business EPS to be between negative 3% and negative 4%.
Sanofi's board proposed a 2017 dividend of EUR3.03, a 2.4% increase over 2016.
Write to Sonia Amaral Rohter at sonia.amaralrohter@dowjones.com
(END) Dow Jones Newswires
February 07, 2018 01:58 ET (06:58 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions